Scopia Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4M Sell
562,260
-1,310,203
-70% -$22.8M 8.5% 2
2025
Q4
$22.1M Sell
1,872,463
-1,013,285
-35% -$13M 4.56% 10
2025
Q3
$45.7M Sell
2,885,748
-469,513
-14% -$6.81M 5.75% 2
2025
Q2
$38.4M Buy
3,355,261
+1,401,539
+72% +$15.8M 4.69% 7
2025
Q1
$26.8M Buy
1,953,722
+555,095
+40% +$9.22M 3.87% 14
2024
Q4
$23.6M Buy
1,398,627
+728,197
+109% +$14.2M 2.5% 17
2024
Q3
$13.6M Buy
+670,430
New +$13.7M 2.81% 19
2020
Q3
Sell
-746,262
Closed -$11.5M 21
2020
Q2
$11.5M Sell
746,262
-126,516
-14% -$1.6M 1.26% 17
2020
Q1
$7.74M Buy
+872,778
New +$12.6M 0.71% 23

Other funds holding CC

Scopia Capital Management's CC Position: Q1 2026 in Review

Scopia Capital Management reduced its Chemours (CC) stake by 70% in Q1 2026, selling an estimated $22.8M and leaving 562,260 shares worth $12.4M. The position accounts for 8.5% of the portfolio, ranked #2.

Scopia Capital Management first reported a position in CC in Q1 2020 and has held it in 9 quarters since. The position peaked at $45.7M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Scopia Capital Management held 562,260 shares of Chemours worth $12.4M as of Q1 2026.
  • Scopia Capital Management sold 1,310,203 Chemours shares in Q1 2026, an estimated $22.8M.
  • Chemours made up 8.5% of Scopia Capital Management's portfolio in Q1 2026, its #2 holding.
  • Scopia Capital Management first reported a position in Chemours in Q1 2020 and has held it in 9 quarters since.
  • Scopia Capital Management's Chemours position peaked at $45.7M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Scopia Capital Management's 13F filing for Q1 2026, filed 15 May 2026.